Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 06, 2025 10:00 ET | Source: Novonesis

Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters

Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem,...
August 21, 2025 02:03 ET | Source: Novonesis (Novozymes A/S)

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9%...
August 20, 2025 13:35 ET | Source: Novonesis (Novozymes A/S)

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and...
July 07, 2025 02:33 ET | Source: Novonesis (Novozymes A/S)

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains...
May 08, 2025 02:00 ET | Source: Novonesis (Novozymes A/S)

Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook

COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The...
February 26, 2025 02:04 ET | Source: Novonesis (Novozymes A/S)

12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025

Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of...
November 07, 2024 02:02 ET | Source: Novonesis (Novozymes A/S)

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%

Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong...
August 27, 2024 10:34 ET | Source: Novozymes A/S

Novonesis delivers strong half-year results and increases full-year outlook

In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...
May 03, 2024 01:57 ET | Source: Novozymes A/S

Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration

For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA...
January 29, 2024 05:27 ET | Source: Novozymes A/S

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...